Tramadol May Increase Risk of Hip Fracture in Older Adults with Post-Traumatic Osteoarthritis.
J Pers Med
; 13(4)2023 Mar 26.
Article
em En
| MEDLINE
| ID: mdl-37108965
ABSTRACT
Tramadol, an analgesic widely used for arthritic pain, is known to have adverse effects. This study investigated the association between the long-term use of tramadol for pain control and subsequent hip fractures in patients aged 60 years or older with posttraumatic osteoarthritis. This population-based retrospective cohort study included patients with posttraumatic osteoarthritis who received tramadol for pain control for more than 90 days within a 1-year period. A control cohort was enrolled using propensity score matching. The primary outcome was a new diagnosis of hip fracture requiring surgery. In total, 3093 patients were classified into each cohort. Tramadol use was identified as a risk factor for hip fracture (adjusted hazard ratio (aHR) 1.41; 95% confidence interval (CI) 1.09-1.82; p = 0.008), especially among patients aged 60-70 years (aHR 2.11; 95% CI 1.29-3.47; p = 0.003) and among male patients (aHR 1.83; 95% CI 1.24-2.70; p = 0.002). This is the first cohort study focusing on the association between long-term tramadol use and hip fracture among older adults with posttraumatic osteoarthritis. Tramadol, as a long-term pain control analgesic for older adults with posttraumatic osteoarthritis, may increase the risk of hip fracture, especially among male patients and those aged 60-70 years.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Pers Med
Ano de publicação:
2023
Tipo de documento:
Article